Suppr超能文献

晶体学分析金属离子与人泛素的结合。

Crystallographic analysis of metal-ion binding to human ubiquitin.

机构信息

Dipartimento Farmaco-Chimico, University of Bari A. Moro, via E. Orabona 4, 70125 Bari, Italy.

出版信息

Chemistry. 2011 Feb 1;17(5):1569-78. doi: 10.1002/chem.201001617. Epub 2010 Dec 10.

Abstract

The metal-binding ability of human ubiquitin (hUb) towards a selection of biologically relevant metal ions and complexes has been probed. Different techniques have been used to obtain crystals suitable for crystallographic analysis. In the first type of experiments, crystals of hUb have been soaked in solutions containing copper(II) acetate and two metallodrugs, Zeise salt (K[PtCl(3)(η(2)-C(2)H(4))]·H(2)O) and cisplatin (cis-[PtCl(2)(NH(3))(2)]). The Zeise salt is used in a test for hepatitis, whereas cisplatin is one of the most powerful anticancer drugs in clinical use. The Zeise salt readily reacts with hUb crystals to afford an adduct with three platinum residues per protein molecule, Pt(3)-hUb. In contrast, copper(II) acetate and cisplatin were found to be unreactive for contact times up to one hour and to cause degradation of the hUb crystals for longer times. In the second type of experiments, hUb was cocrystallized with a solution of copper(II) or zinc(II) acetate or cisplatin. Zinc(II) acetate gives, at low metal-to-protein molar ratios (8:1), crystals containing one metal ion per three molecules of protein, Zn-hUb(3) (already reported in previous work), whereas at high metal-to-protein ratios (70:1) gives crystals containing three Zn(II) ions per protein molecule, Zn(3)-hUb. In contrast, once again, copper(II) acetate and cisplatin, even at low metal-to-protein ratios, do not give crystalline material. In the soaking experiment, the Zeise anion leads to simultaneous platination of His68, Met1, and Lys6. Present and previous results of cocrystallization experiments performed with Zn(II) and other Group 12 metal ions allow a comprehensive understanding of the metal-ion binding properties of hUb with His68 as the main anchoring site, followed by Met1 and carboxylic groups of Glu16, Glu18, Glu64, Asp21, and Asp32, to be reached. In the case of platinum, Lys6 can also be a binding site. The amount of bound metal ion, with respect to that of the protein, appears to be a relevant parameter influencing crystal packing.

摘要

已探究了人源泛素(hUb)与一系列生物相关金属离子和配合物的金属结合能力。使用了不同的技术来获得适合晶体学分析的晶体。在第一类实验中,将 hUb 晶体浸泡在含有铜(II)乙酸盐和两种金属药物的溶液中,这两种金属药物分别是 Zeise 盐(K[PtCl(3)(η(2)-C(2)H(4))]·H(2)O)和顺铂(cis-[PtCl(2)(NH(3))(2)])。Zeise 盐用于肝炎测试,而顺铂是临床使用的最有效抗癌药物之一。Zeise 盐很容易与 hUb 晶体反应,每个蛋白质分子提供三个铂残基的加合物,Pt(3)-hUb。相比之下,铜(II)乙酸盐和顺铂在接触时间长达一小时内没有反应,并且在更长时间内导致 hUb 晶体降解。在第二类实验中,将 hUb 与铜(II)或锌(II)乙酸盐或顺铂的溶液共结晶。锌(II)乙酸盐在低金属与蛋白质摩尔比(8:1)下生成每个蛋白质分子含一个金属离子的晶体,Zn-hUb(3)(在之前的工作中已有报道),而在高金属与蛋白质摩尔比(70:1)下生成每个蛋白质分子含三个锌(II)离子的晶体,Zn(3)-hUb。相比之下,再次说明铜(II)乙酸盐和顺铂即使在低金属与蛋白质的摩尔比下,也不能得到晶体物质。在浸泡实验中,Zeise 阴离子导致 His68、Met1 和 Lys6 同时铂化。当前和以前进行的与 Zn(II)和其他第 12 族金属离子共结晶实验的结果允许全面理解 hUb 的金属离子结合特性,其中 His68 是主要的锚定位点,其次是 Met1 和 Glu16、Glu18、Glu64、Asp21 和 Asp32 的羧基。对于铂,Lys6 也可以是结合位点。与蛋白质相比,结合的金属离子量似乎是影响晶体堆积的一个相关参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验